Medika d.d.

ZSE-MDKA
Zagreb Stock Exchange
Drugs, Drug Proprietaries, and Druggists' Sundries
Global Rank
#21247
Country Rank
#22
Market Cap
165.24 M
Price
695.9
Change (%)
2.08%
Volume
4

Medika d.d.'s latest marketcap:

165.24 M

As of 06/26/2025, Medika d.d.'s market capitalization has reached $165.24 M. According to our data, Medika d.d. is the 21247th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 165.24 M
Revenue (ttm) 927.6 M
Net Income (ttm) 22.63 M
Shares Out 28,954
EPS (ttm) 781.44
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 07/31/2025
Market Cap Chart
Data Updated: 06/26/2025

Medika d.d.'s yearly market capitalization.

Medika d.d. has seen its market value drop from 348.47 M HRK to 165.24 M HRK since 2014, representing a total decrease of 52.58% and an annual compound decline rate (CAGR) of 6.81%.
Date Market Cap(HRK) Change (%) Global Rank
06/26/2025 165.24 M -3.03% 21247
12/30/2024 1.17 B -23.02% 48681
12/11/2023 1.51 B 77.85% 47003
12/19/2022 851.25 M 2.08% 21077
12/30/2021 833.88 M 69.98% 21666
12/30/2020 490.57 M 11.8% 21948
12/30/2019 438.79 M -2.18% 37226
12/28/2018 448.56 M 7.82% 35810
12/29/2017 416.04 M -18.47% 34261
12/30/2016 510.28 M 41.37% 32214

Company Profile

About Medika d.d.

Medika d.d., along with its subsidiaries, specializes in the wholesale and retail distribution of pharmaceutical products across the Republic of Croatia.

Core Business Activities

The company focuses on:

  • Selling, storing, and distributing human and veterinary medicines
  • Providing medical products, equipment, and dental aids
  • Offering cosmetics, dietary supplements, hygiene products, and other healthcare market essentials

Customer Base

Medika serves a diverse range of clients, including:

  • Pharmacies and pharmaceutical wholesale companies
  • Healthcare institutions, hospitals, and clinics
  • Medical practices and polyclinics
  • Veterinary clinics and dental offices
  • Herbal pharmacies, optical shops, and specialized stores

Company Background

Founded in 1922, Medika d.d. is headquartered in Zagreb, Croatia, and has established itself as a trusted name in the pharmaceutical distribution sector.

Frequently Asked Questions

  • What is Medika d.d.'s (ZSE-MDKA) current market cap?
    As of 06/26/2025, Medika d.d. (including the parent company, if applicable) has an estimated market capitalization of $165.24 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Medika d.d. global market capitalization ranking is approximately 21247 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.